Adverse Drug Reaction Reporting in the UKA Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals

被引：0
|
作者：
David J. McLernon
Christine M. Bond
Philip C. Hannaford
Margaret C. Watson
Amanda J. Lee
Lorna Hazell
Anthony Avery
机构：
[1] University of Aberdeen,Medical Statistics Team, Section of Population Health
[2] Drug Safety Research Unit,undefined
[3] Nottingham University Medical School,undefined
来源：
Drug Safety | 2010年 / 33卷
关键词：
Healthcare Professional; Adverse Drug Reaction; Adverse Drug Reaction Reporting; Suspect Drug; System Organ Class;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: In the UK, spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals has been in operation since 1964 through the Yellow Card Scheme (YCS). From 2005, patients themselves have been able to submit Yellow Card reports.
引用
收藏
页码：775 / 788
页数：13
相关论文
共 50 条
  • [1] Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
    McLernon, David J.
    Bond, Christine M.
    Hannaford, Philip C.
    Watson, Margaret C.
    Lee, Amanda J.
    Hazell, Lorna
    Avery, Anthony
    [J]. DRUG SAFETY, 2010, 33 (09) : 775 - 788
  • [2] Comparison of Adverse Drug Reaction (ADR) Reports Submitted to the FDA by Consumers and Healthcare Professionals (HCPs)
    Alshammari, Thamir M.
    Ahmad, Syed Rizwanuddin
    Swartz, Lynette
    Hammad, Tarek A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S4 - S5
  • [3] The Yellow Card Scheme for reporting adverse drug reactions (ADRs) by patients in the UK will complement, not replace, the Yellow Card reports
    [J]. Reactions Weekly, 2006, 1109 (1) : 3 - 3
  • [4] Adverse Drug Reaction Reports of Patients and Healthcare Professionals; How Different Are They?
    Rolfes, Lean
    van Hunsel, Florence
    van Puijenbroek, Eugene
    van Grootheest, Kees
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 315 - 315
  • [5] The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
    Rolfes, Lean
    van Hunsel, Florence
    van der Linden, Laura
    Taxis, Katja
    van Puijenbroek, Eugene
    [J]. DRUG SAFETY, 2017, 40 (07) : 607 - 614
  • [6] The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
    Leàn Rolfes
    Florence van Hunsel
    Laura van der Linden
    Katja Taxis
    Eugène van Puijenbroek
    [J]. Drug Safety, 2017, 40 : 607 - 614
  • [7] The Documentation of Clinical Information of Adverse Drug Reaction Reports: A Paired Comparison of 'Duplicate' Reports of Patients and Healthcare Professionals
    Rolfes, Lean
    van der Linden, Laura
    van Hunsel, Florence
    Taxis, Katja
    van Puijenbroek, Eugene
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 418 - 419
  • [8] Adverse drug reaction reports of patients and healthcare professionals-differences in reported information
    Rolfes, Lean
    van Hunsel, Florence
    Wilkes, Sarah
    van Grootheest, Kees
    van Puijenbroek, Eugene
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (02) : 152 - 158
  • [9] Attitudes of Healthcare Professionals towards Adverse Drug Reaction Reporting in Nepal
    Santosh, K. C.
    Tragulpiankit, Pramote
    Gorsanan, Sarun
    Edwards, Ralph
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S337 - S337
  • [10] Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting
    Aung, Ar Kar
    Tang, Mei Jie
    Adler, Nikki Rae
    de Menezes, Sara Lee
    Goh, Michelle Sue Yen
    Tee, Hui Wen
    Trubiano, Jason Anthony
    Puy, Robert
    Zubrinich, Celia Mary
    Graudins, Linda Velta
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (10): : 1332 - 1339
12345